Treatment of cells with microtubule inhibitors results in activation of the mitotic spindle assembly checkpoint, leading to mitotic arrest before anaphase. Upon prolonged treatment, however, cells can adapt and exit mitosis aberrantly, resulting in the occurrence of tetraploid cells in G1. Those cells subsequently arrest in postmitotic G1 due to the activation of a p53-dependent G1 checkpoint. Failure of the G1 checkpoint leads to endoreduplication and further polyploidization. Using HCT116 and isogenic p53-deficient or spindle checkpoint compromised derivatives, we show here that not only p53 but also a functional spindle assembly checkpoint is required for postmitotic G1 checkpoint function. During transient mitotic arrest, p53 stabilization and activation is triggered by a pathway independent of ATM/ATR, Chk1 and Chk2. We further show that a prolonged spindle checkpoint-mediated mitotic arrest is required for proper postmitotic G1 checkpoint function. In addition, we demonstrate that polyploid cells are inhibited to re-enter mitosis by an additional checkpoint acting in G2. Thus, during a normal cell cycle, polyploidization and subsequent aneuploidization is prevented by the function of the mitotic spindle checkpoint, a p53-dependent G1 checkpoint and an additional G2 checkpoint.
Introduction
During tumorigenesis, polyploidy frequently precedes aneuploidy, which is associated with high malignancy and poor prognosis Duesberg and Li, 2003; Rajagopalan et al., 2003) . Although the molecular basis for polyploidy observed in human cancer is largely unknown, it is conceivable that polyploidy can be generated by uncoupling DNA replication from completion of mitosis. During mitosis, proper sister chromatid segregation is monitored by the mitotic spindle assembly checkpoint, which inhibits anaphase onset until all chromosomes are properly attached to the mitotoic spindle apparatus and aligned at the metaphase plate (for reviews, see Shah and Cleveland, 2000; Wassmann and Benezra, 2001; Chan and Yen, 2003) . The molecular machinery of the spindle checkpoint involves the function of proteins, including Cenp-E, Bub1, BubR1, Bub3, Mad1, Mad2 and Mps1, which are recruited specifically to kinetochores that are not attached to the mitotic spindle. Although the significance of various protein-protein interactions observed during spindle checkpoint activation is not well understood, it is widely accepted that Mad2 represents the distal effector protein that becomes activated at kinetochores. Mad2 inhibits the anaphasepromoting complex/cyclosome (APC/C) by direct binding and this results in stabilization of proteins including securin and cyclin B, whose degradation is required for anaphase onset and mitotic exit (Li et al., 1997; Fang et al., 1998; Gorbsky et al., 1998) . Therefore, activation of the spindle checkpoint inhibits anaphase onset and mitotic exit.
In normal cells, prolonged treatment with spindledamaging agents like nocodazole or taxol leads to transient pre-anaphase arrest due to the activation of the spindle checkpoint, followed by an aberrant exit from mitosis without sister chromatid segregation and cytokinesis, a process known as mitotic slippage. However, the resulting tetraploid cells arrest in G1, comprising a novel postmitotic G1 checkpoint preventing entry into the S phase and polyploidization (Meek, 2000; Margolis et al., 2003) . Cells lacking either p53, p21 or pRb arrest in mitosis normally in response to spindle damage, but after mitotic slippage these cells enter S phase and endoreduplicate their DNA, resulting in polyploidization despite their intact spindle checkpoint, indicating a strict dependence of the postmitotic G1 checkpoint on the p53-pRb pathway (Di Leonardo et al., 1997; Khan and Wahl, 1998; Lanni and Jacks, 1998; Casenghi et al., 1999; Stewart et al., 1999) . Thus, the activation of p53 protects normal cells from polyploidization. In addition, using inhibitors of cytokinesis tetraploid cells can be generated without spindle damage or segregation defects. Those cells also activate p53, leading to an arrest in G1, suggesting that tetraploidization itself rather than aberrant exit from mitosis is triggering the p53 response (Andreassen et al., 2001) . Nevertheless, the molecular mechanisms leading to p53 activation in response to mitotic failure are unknown. Interestingly, it has been observed that HeLa cells overexpressing a dominant-negative mutant of BUB1 or HCT116 cells exhibiting reduced levels of Mad2 (HCT116-MAD2 þ /À cells) escape from mitotic arrest and subsequently endoreduplicate, despite the fact that HCT116 cells possess intact p53 (Taylor and McKeon, 1997; Michel et al., 2001) . These observations strongly suggest a possible functional interplay between the mitotic spindle checkpoint and the p53-dependent postmitotic G1 checkpoint.
Here we investigated a functional interaction between the p53-dependent postmitotic G1 checkpoint and spindle checkpoint activation. We found that p53, together with an intact spindle checkpoint, is required to prevent endoreduplication upon mitotic failure. p53 is activated during spindle checkpoint-mediated mitotic arrest and this arrest is required to ensure G1 checkpoint functionality. In spindle checkpoint compromised cells, mitotic arrest is shortened, resulting in subsequent endoreduplication. Moreover, extending the time of mitotic arrest in these cells inhibits endoreduplication. In addition, we identified a spindle damagetriggered checkpoint mechanism, which arrests cells in G2, preventing polyploid cells to re-enter mitosis. Thus, prevention of polyploidy requires a functional spindle checkpoint, a p53-dependent G1 checkpoint and a novel spindle damage-triggered G2 checkpoint.
Results

Spindle checkpoint and p53-deficient cells endoreduplicate upon prolonged spindle damage
To investigate a functional interaction between the mitotic spindle assembly checkpoint and postmitotic p53-dependent G1 checkpoint activation, we took advantage of a panel of isogenic cells derived from HCT116 human colon carcinoma cells. HCT116 cells are well characterized with respect to their intact DNA damage checkpoint, normal p53 responses and an intact spindle assembly checkpoint. We used HCT-p53 (Michel et al., 2001) and two independent HCT-MAD1 knockdown clones (HCT-MAD1-kd-2-2 and HCT-MAD1-kd-2-31) in which siRNA targeting MAD1 is stably expressed from the pSUPER vector in HCT116 cells (A Kienitz, C Vogel, R Mu¨ller, H Bastians, manuscript in preparation). HCT-MAD2
þ /À and HCT-MAD1-kd cells display reduced Mad2 and Mad1 protein levels, respectively (Michel et al., 2001 ; data not shown). After treatment with nocodazole to activate the spindle checkpoint for 16 h HCT116 wild type, a control cell line containing a stably integrated pSUPER vector (HCT þ pSUPER) and p53-deficient derivatives accumulate in mitosis at a high rate, indicating an intact spindle assembly checkpoint and showing that p53 is not required for spindle checkpoint activation ( Figure 1a ). As expected, HCT-MAD2 þ /À and both HCT-MAD1 knockdown clones showed a compromised spindle checkpoint activation, as shown by strongly reduced mitotic index after 16 h of nocodazole treatment (Figure 1a) . We treated all cell lines with nocodazole for up to 48 h, determined the DNA content and found, in agreement with previous work, that p53-deficient cells endoreduplicate, becoming octaploid upon aberrant exit from mitosis. Importantly, all the three spindle checkpoint compromised cell lines also endoreduplicate (Figure 1b) . Quantification of cell populations containing a DNA content 44 N revealed that these cell lines arrest in mitosis for a short time and endoreduplicate already 16 h after treatment. p53-deficient cells, however, arrest in mitosis and endoreduplicate after 24 h of treatment (Figure 1c ). To confirm a G1 arrest in HCT wild-type cells and S-phase entry of p53-deficient and spindle checkpoint compromised cells, we evaluated the protein levels of cyclin A, cyclin B and cdc2 following nocodazole treatment on Western blots. In agreement with previous studies (Stewart et al., 1999) , wild-type cells arrested in G1 show decreased cyclin A and B levels, which are also accompanied with a decrease of cdc2 levels ( Figure 1d ). In contrast, p53-deficient cells show only transient downregulation of cyclin A and B upon mitotic exit, and strong reaccumulation when cells enter S phase accompanied with continuous high-level expression of cdc2, indicating the cycling status of these cells (Figure 1d ). Both spindle checkpoint compromised cell lines exit mitosis and enter the S phase earlier supported by high levels of cyclin A and B after incubation with nocodazole for up to 32 h. At later time points, however, these cells contain low levels of cyclin A, cyclin B and cdc2, suggesting a cell cycle arrest after prolonged nocodazole treatment (Figure 1d ). Consistent with this observation, we found that the number of p53-deficient cells with a 44 N DNA content appear to accumulate continuously, while spindle checkpoint compromised cells reach a maximum of cells with 44 N at 32 h ( Figure 1c ). To test whether p53-deficient cells keep cycling and spindle checkpoint compromised cells indeed arrest upon prolonged spindle poison treatment, we pulse-labelled cells with BrdU and determined the time window of DNA replication ( Figure 1e ). p53-deficient cells slip out of mitosis after about 24 h (data not shown) and continuously replicate, indicating endoreduplication for up to 72 h. However, spindle checkpoint compromised cells replicate at a high rate for only up to 24 h, reflecting early mitotic slippage and subsequent DNA replication. Upon prolonged spindle damage for up to 72 h, these cells indeed arrest in G1 and possibly in G2. Our data support the notion that p53-deficient cells continue to replicate even after 72 h of nocodazole treatment, suggesting that a fraction of these cells continue to cycle in the presence of spindle damage. Consistent with this observation, we found that a fraction of p53-deficient but not of spindle checkpoint compromised cells contain DNA contents of 48 N after 48, 72 and 96 h of nocodazole treatment ( Figure 1f ).
Spindle damage activates p53 during the spindle checkpoint-mediated mitotic arrest
The postmitotic G1 arrest in response to spindle damage and aberrant exit from mitosis is dependent on p53 and expression of its target gene p21. We verified that in HCT116 cells p53 and p21 properly accumulate upon nocodazole or taxol treatment (Figure 2a ; data not shown). It was suggested that p53 activation is triggered by the tetraploidy state itself rather than by mitotic defects (Andreassen et al., 2001) . To determine whether p53 stabilization is triggered directly by spindle damage during mitosis or upon abnormal mitotic exit associated with tetraploidy in G1, we determined the timepoint of p53 stabilization. We isolated equal amounts of mitotic HCT116 cells treated for 8 and 16 h with either nocodazole or taxol by shakeoff and determined the level of p53 protein by Western blotting (Figure 2b) . In both experiments, we detected a time-dependent accumulation of p53 protein in mitotic cells, indicating that stabilization of p53 is initiated during the spindle checkpoint-mediated mitotic arrest. Further, on Northern blots we quantified the mRNA of p21 Cip1 (p21) as an example of a p53 target gene and found an initial induction of p21 mRNA in mitotic cells (our unpublished results). Thus, after spindle damage, induced by nocodazole or taxol, p53 activation is triggered during spindle checkpoint-mediated mitotic arrest. Similar results were obtained using monastrol as a spindle checkpoint-activating agent (Mayer et al., 1999) , indicating that mitotic p53 activation is not dependent on the nature of the mitotic damage but rather on the prolonged spindle checkpoint-mediated mitotic arrest. In agreement with this, we could not observe any p53 accumulation during a normal mitosis when the spindle assembly checkpoint is activated (data not shown).
Spindle damage-induced p53 activation does not require components of the DNA damage pathway
To address the question of how p53 is activated during mitosis, we investigated a possible involvement of ATM, ATR, Chk1 and Chk2, checkpoint kinases that are involved in p53 activation upon DNA damage. First, we used caffeine as a known inhibitor of the ATM and ATR kinases (Blasina et al., 1999; Hall-Jackson et al., 1999) and found no significant effect on p53 stabilization, induction of p21 or postmitotic G1 arrest after spindle damage. However, caffeine at the concentration used inhibits p53 accumulation and activation of p53 and abolishes cell cycle arrest after DNA damage induced by adriamycin ( Figure 3a , left panel; data not shown). This suggests that p53 is activated in response to spindle damage independent of ATM/ATR. To test for an involvement of Chk1, we used UCN-01 and Go¨6976 as established inhibitors for Chk1 kinase activity (Graves et al., 2000; Kohn et al., 2003) . Pretreatment of HCT116 cells with UCN-01 or Go¨6976 followed by incubation with adriamycin or nocodazole had no effect on p53 accumulation, p21 induction and G1 arrest after spindle damage, while Crosstalk of the spindle checkpoint with p53 C Vogel et al UCN-01 abolishes G2 arrest in adriamycin-treated cells, demonstrating an inactivation of Chk1 during p53-independent G2 arrest after DNA damage ( Figure 3a , lower panel; data not shown). Chk2 is thought to be an important upstream regulator of p53 (for a review, see McGowan, 2002) . To test whether Chk2 is involved in p53 activation in response to spindle damage, we used recently established HCT116 cells homozygously deleted for CHK2 (Jallepalli et al., 2003) . Upon prolonged nocodazole and adriamycin treatment, HCT-CHK2 À/À cells showed similar p53 and p21 accumulation as in HCT116 wild-type cells (Figure 3b ), suggesting that Chk2 is neither required for p53 activation after adriamycin treatment nor upon prolonged spindle damage.
Prolonged mitotic arrest is required for proper postmitotic G1 arrest upon mitotic failure
Given the fact that spindle checkpoint compromised cells endoreduplicate after mitotic failure and that the postmitotic G1 arrest is dependent on p53, we investigated whether an intact spindle assembly checkpoint is required for p53 accumulation upon spindle damage. We compared the p53 levels of HCT116 control cells, HCT-MAD2 þ /À and HCT-MAD1-kd cells after spindle damage on Western blots, and found no significant differences in p53 stabilization in all the three cell lines (Figure 4a ). Similar results were obtained after DNA damage induced by adriamycin (data not shown). Next, we tested whether a prolonged mitotic arrest, which occurs in response to spindle damage in wild-type cells but not in spindle checkpoint compromised cells, is required to prevent endoreduplication (Figure 4b) . We incubated HCT116, HCT-MAD1-kd and HCT-MAD2 þ /À cells with nocodazole for 8 h, isolated arrested cells by mitotic shakeoff and treated them either with DMSO as a control or with the proteasome inhibitor ALLN in order to prolong the metaphase arrest independent of the spindle checkpoint status of the cells. After 4 h, the proteasome inhibitor was washed off and aberrant exit from mitosis in the presence of nocodazole and further progression in G1 was monitored by FACS analyses and determination of the 
treatment with adriamycin (14 h) and nocodazole (40 h) was determined by FACS analyses
Crosstalk of the spindle checkpoint with p53 C Vogel et al mitotic index (data not shown). After 32 h of nocodazole treatment, cells were harvested and the proportion of cells which had undergone endoreduplication was determined by FACS analyses. As predicted, ALLN treatment kept all the three spindle checkpoint compromised cell lines in a prometaphase arrest state until they were washed off (data not shown). Most importantly, spindle checkpoint compromised cells forced to arrest in mitosis showed a significant reduction of endoreduplication (Figure 4b ), suggesting that a prolonged mitotic arrest mediated by normal activation of the spindle assembly checkpoint is required for an efficient postmitotic G1 arrest.
Spindle damage triggers a G2 checkpoint that prevents re-entry into mitosis During tumorigenesis, polyploidy seems to be a frequent precursor of aneuploidy (Shackney et al., 1989) , which might occur through endoreduplication associated with centrosome amplification and subsequent reentry into mitosis (Borel et al., 2002; Meraldi et al., 2002) . To investigate whether p53-deficient and spindle checkpoint compromised cells that have undergone endoreduplication would re-enter mitosis, we determined the proportion of octaploid mitotic cells in
HCT-p53
À/À , HCT-MAD1-kd and HCT-MAD2 þ /À cell lines by MPM2-FACS analyses (Figure 5a ). We found that a significant proportion of octaploid p53-deficient cells (about 15% after 48 h) had entered mitosis after endoreduplication, whereas octaploid HCT-MAD1-kd and HCT-MAD2 þ /À cells arrested in G2 (Figure 5b ). This finding is in agreement with our observation that p53-deficient cells but not spindle checkpoint compromised cells continue to cycle in the presence of spindle damage (Figure 1e and f) . This indicates the existence of an additional p53-dependent checkpoint mechanism that prevents polyploid cells from re-enter mitosis.
Discussion
Aneuploidy and polyploidy are frequent in human solid tumors and could be explained by cells gaining or losing whole chromosomes or large fractions thereof at high frequency, which is referred to as chromosome instability (CIN). To date, the genetic lesions causing CIN are largely unknown. As aneuploidy can be directly a consequence of missegregation of chromosomes during mitosis, mutations in spindle checkpoint genes have been discussed for causing CIN (Rajagopalan et al., 2003) . In addition, it is observed 
HCT116-wild-type (wt), HCT-MAD2
þ /À and HCT-MAD1-kd cells were treated with 150 nM nocodazole and isolated by shake-off. Mitotic cells were either treated with DMSO (control) or with the proteasome inhibitor ALLN for additional 4 h to arrest cells in mitosis independent of the spindle checkpoint activation, followed by washout of ALLN. Cells were harvested after 32 h in nocodazole and the proportion of cells containing a 44 N DNA content was calculated. The graph shows the mean values and standard error from three independent experiments Crosstalk of the spindle checkpoint with p53 C Vogel et al that polyploidy often precedes aneuploidy during tumorigenesis (Shackney et al., 1989) . It is therefore of great interest to unravel the mechanisms underlying aneuploidy and polyploidy.
Polyploidy upon aberrant exit from mitosis is prevented by a p53-dependent postmitotic G1 checkpoint
Prolonged treatment with spindle poisons leads to an aberrant exit from mitosis, resulting in tetraploidy due to adaptation of the mitotic spindle assembly checkpoint. Although the nature of the mitotic checkpoint adaptation is unknown, previous studies have shown that cells exiting aberrantly from mitosis activate subsequently a p53-dependent G1 checkpoint, which arrests cells in the postmitotic G1 phase (Di Leonardo et al., 1997; Khan and Wahl, 1998; Lanni and Jacks, 1998; Casenghi et al., 1999; Stewart et al., 1999; Meek, 2000; Margolis et al., 2003) . Inactivation of p53 not only leads to endoreduplication but also to centrosome amplification, giving rise to multipolar spindles and thus missegregation of the genome. This might possibly explain why polyploidy often precedes aneuploidy during tumorigenesis (Borel et al., 2002; Meraldi et al., 2002) . In our work, we demonstrate that p53 is stabilized and activated during a spindle checkpoint-induced mitotic arrest, rather than upon aberrant exit from mitosis and generation of a tetraploid state. It is yet unclear how p53 is activated during mitotic arrest, but it has been shown previously that the phosphorylation pattern on p53 is distinct after DNA damage and after spindle damage, suggesting a separate signalling pathway that activates p53 during mitotic arrest and after DNA damage, respectively (Stewart et al., 2001) . Moreover, our data indicate that activation of p53 during mitosis occurs independent of components of the p53-dependent DNA damage checkpoint pathway, including ATM, ATR, Chk1 and Chk2. In fact, in a first attempt to identify signalling components of this novel pathway activating p53 after spindle damage, we used a panel of kinase inhibitors and found that the phosphatidylinositol-3-kinase inhibitor LY294002 strongly inhibits the accumulation of p53 associated with reduced p21 expression after spindle damage. This suggests a possible involvement of PI3-kinase or PI3-kinase-related kinase in this novel signalling pathway (our unpublished results).
An intact spindle checkpoint is required for proper postmitotic G1 checkpoint function
In our work, we could show that not only intact p53 but also an intact spindle assembly checkpoint is required for postmitotic G1 arrest and therefore for prevention of polyploidy upon aberrant mitotic exit. Moreover, we have demonstrated that a prolonged mitotic arrest is critical for postmitotic G1 arrest, indicating the time of mitotic arrest to be critical for proper p53 activation. We did not find significant defects in p53 stabilization, neither after spindle nor upon DNA damage. However, our preliminary analysis of the expression of two p53 target genes, bax and p21, after spindle damage suggests that the transcriptional activation of p53 might be altered in spindle checkpoint compromised cells after spindle damage (our unpublished results). Thus, it is tempting to speculate that proper transcriptional activation of p53, which is essential for preventing polyploidy, occurs during a prolonged mitotic arrest.
p53 -a surveillance factor for mitotic defects?
Although we and others have shown that p53 is clearly not required for spindle checkpoint activation and for mitotic arrest, there are several lines of evidence that p53 might be an important surveillance factor for mitotic defects: (i) p53 is activated in response to various mitotic defects (Morris et al., 2000; Andreassen et al., 2001) , (ii) p53 is localized to centrosomes during mitosis and is displaced upon spindle damage (Ciciarello et al., 2001) , (iii) 53BP1, a p53 interacting protein implicated in the early response to DNA damage, is localized at kinetochores during mitosis and upon spindle damage, resembling the localization of spindle checkpoint proteins (Jullien et al., 2002) , (iv) Chk2, an important regulator of p53, is localized to centrosomes and interacts with polo-like kinase 1, which is involved in several aspects of mitotic regulation (Tsvetkov et al., 2003) .
It is conceivable that p53 is activated in response to various mitotic defects including spindle damage, centrosome malfunction, prolonged mitotic delay and tetraploidization to act as a second fail-safe mechanism in G1 that prevents endoreduplication after mitotic failure.
An additional checkpoint in G2 prevents aneuploidy upon polyploidization
As inactivation of p53 is frequent in tumor cells, one would expect that the postmitotic G1 checkpoint is suppressed in tumors, which in turn would allow polyploidization and subsequent aneuploidization. We have shown that an additional checkpoint mechanism exists that arrests cells in G2 in response to mitotic failure and polyploidization. Polyploid p53-deficient cells can re-enter mitosis, whereas polyploid spindle checkpoint compromised p53-proficient cells stably arrest in G1 and G2 upon prolonged spindle damage. Therefore, we suggest that this novel G2 checkpoint also involves the function of p53. Moreover, in our preliminary experiments by using caffeine and UCN-01 as inhibitors for ATM/ATR and Chk1 kinases, respectively, we observe a significant increase of p53-deficient cells entering mitosis, suggesting that ATM/ATR and Chk1 together with p53 might be involved in the spindle damage activated G2 checkpoint (our unpublished results).
These results, together with our data showing a high rate of DNA synthesis and the generation of hyperoctaploid DNA contents in p53-deficient cells in the presence of spindle poisons, suggest that p53 might represent a key surveillance factor to prevent polyploidy and most likely aneuploidy after mitotic failure. However, p53-deficient cells are not polyploid or aneuploid per se (Bunz et al., 1998) , suggesting that additional genes are required to prevent polyploidy and aneuploidy. As we have shown here, spindle checkpoint genes that are required to prevent polyploidy might be prime candidates.
Materials and methods
Cell culture
HCT116 (wild type for TP53, CHK2, MAD1 and MAD2), HCT116-p53 À/À (Bunz et al., 1998) and HCT116-CHK2 À/À cells (Jallepalli et al., 2003) were generously provided by Dr Bert Vogelstein (Baltimore, MD, USA). HCT116-MAD2 þ /À cells (Michel et al., 2001 ) were a kind gift from Dr Loren Michel and Dr Robert Benezra (New York, NY, USA). HCT116-MAD1 knockdown cells were generated by stable transfection of pSUPER (Brummelkamp et al., 2002) expressing siRNA targeting human MAD1 (a detailed characterization of the MAD1 knockdown cells will be described elsewhere). All cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum, 1% glutamine and 100 mg/ml streptomycin and 100 U/ml penicillin (Gibco) at 371C under 95% water and 5% CO 2 atmosphere. When indicated cells were treated with 150 nM nocodazole (Sigma), 100 nM taxol (Sigma), 68 mM monastrol (Sigma) or 200 mM ALLN (Calbiochem).
Western blotting
For Western blot analyses, cells were lysed in ice-cold lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% (v/v) Nonidet-P-40, 0.1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS) containing protease inhibitors (Complete, Roche, Germany). Cellular debris was removed by centrifugation and the supernatants were snap frozen and stored at À801C. Proteins were resolved by electrophoresis on SDS/12.5 or 14% polyacrylamide gels and transferred onto nitrocellulose membranes. Blocking of the membrane and antibody incubations were performed in TBS plus 5 and 2% nonfat dry milk, respectively. Immunoblots were developed using enhanced chemiluminescence (SuperSignal, Pierce). The following antibodies were used: anti-p53 (DO-1; PAb1801, Oncogene, San Diego, CA, USA), anti-p21 (Oncogene, San Diego, CA, USA), anti-cyclin A (Santa Cruz, CA, USA), anticyclin B (Santa Cruz, CA, USA), anti-cdc2 (Santa Cruz, CA, USA), anti-actin (Sigma) and secondary antibodies conjugated to HRP (Jackson ImmunoResearch, PA, USA).
Determination of the DNA content
Cells were fixed in 70% ethanol for at least 16 h, resuspended in PBS and treated with 1 mg/ml RNase for 16 h. DNA was stained using 50 mg/ml propidium iodide and analysed on a FACS Calibur (Becton Dickinson).
Determination of the mitotic index
To determine the mitotic index, fixed cells were incubated for 2 h on ice with 2.5 mg/ml anti-MPM2 antibodies (Upstate, UK) diluted in PBS, 0.2% Triton-X-100 and 2% FCS. Cells were washed twice and incubated for 1 h on ice with goatanti-mouse-DTAF antibodies (1 : 100, Jackson ImmunoResearch). Cells were treated with RNase, DNA was stained with propidium iodide and cells were analysed on a FACS Calibur (Becton Dickinson).
Determination of BrdU incorporation
To measure the incorporation of BrdU, cells were pulselabelled with 50 mM BrdU (Sigma) for 1 h. Cells were fixed in ethanol for 24 h and rehydrated in PBS, 0.5% BSA. DNA was denatured with 2 M HCl in water for 25 min at RT. Cells were washed and incubated for 1 h with anti-BrdU antibodies (diluted 1 : 200 in PBS, 0.5% BSA, 0.5% Tween-20). Cells were then processed as described for MPM2 staining.
